Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by skys1on May 14, 2017 10:51am
260 Views
Post# 26241984

Deals???

Deals???We already know 1433 kills human cancer cells. I think by now we know it doesn't cause detrimental effects to the patient as there has been time to examine the scans of patients 1 & 2, and the trial is still open. That wouldn't be the case if problems had developed. After all these years of waiting, "wishin an hopein", TLT has finally proven they "have the goods". Venture Guy said, "that's what makes millionaires". We are in a superior position. Now is not the time to sell out. Let the word get out and the price go up for a while, and a jump to the NAS, then the only deal I'd be interested in would be, "we'll let you use our 1433 and our technology for 30% of revenue, we'll handle and keep the laser sales. We do that for half dozen or so cancers and we will all be living in $zillionaire land.
Bullboard Posts